The Society for Integrative Oncology will hold its second international conference this November at the Manchester Grand Hyatt Hotel in San Diego, California.
Held in collaboration with Memorial Sloan-Kettering Cancer Center, the National Certification Commission for Acupuncture and Oriental Medicine, and other leading health organizations, the meeting is designed to offer health care providers the latest information on the use of integrative medicine in the treatment of cancer.
The Society is a non-profit, multidisciplinary organization of professionals dedicated to studying and facilitating the cancer treatment and recovery process through the use of integrated complementary therapies. Its overlying mission is to educate oncology professionals, patients, caregivers and other interested parties about state-of-the-art integrative therapies, including their scientific validity, clinical benefits, toxicities, and limitations. Several licensed acupuncturists currently belong to the organization's scientific committee, including Kabba Anand, Joseph Chiang, Lixing Huang, and Leanna Standish.
This year's conference features a keynote address by Dr. Michael Baum, a visiting professor of medical humanities at the University College of London. The conference will also include a satellite workshop titled "Acupuncture in Oncology Practice and Research." Other presentations currently in development include "Acupuncture for Symptom Management," "Nutritional and Micronutrient Approaches," and "Mind-Body Medicine in Cancer."
Abstracts are currently being accepted for the conference, with a final submission deadline of July 22. Abstracts may be submitted on a variety of topics, including:
common physical symptoms
common emotional/psychological symptoms
botanicals and natural products in the treatment of cancer
botanicals and natural products in the treatment of cancer-related symptoms
phytoestrogens, antioxidants and nutritional therapy
Comments are encouraged, but you must follow our User Agreement
Keep it civil and stay on topic. No profanity, vulgar, racist or hateful comments or personal attacks. Anyone who chooses to exercise poor judgement will be blocked. By posting your comment, you agree to allow MPA Media the right to republish your name and comment in additional MPA Media publications without any notification or payment.